当前位置:首页 - 行情中心 - 永顺生物(839729) - 财务分析

永顺生物

(839729)

  

流通市值:8.13亿  总市值:28.92亿
流通股本:7682.50万   总股本:2.73亿

永顺生物(839729)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.29亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益64895.86万元,未分配利润11692.08万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产78780.21万元,负债13884.35万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入200,361,538.4119,176,173.4466,495,478.87314,282,861.48
营业总成本171,882,299.31101,264,705.657,569,882.86258,618,527.57
营业利润32,416,644.5117,281,855.029,360,944.9961,103,036.71
利润总额32,528,900.5917,374,117.049,420,501.365,280,847.31
净利润28,963,470.1915,533,898.418,374,511.5158,058,744.25
其他综合收益----
综合收益总额28,963,470.1915,533,898.418,374,511.5158,058,744.25
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计583,675,829.04559,004,905.13584,482,912.07563,546,980.74
非流动资产合计204,126,306.84210,343,359.1217,383,096.16224,312,983.97
资产总计787,802,135.88769,348,264.23801,866,008.23787,859,964.71
流动负债合计129,359,533.08123,639,340.13114,482,878.12108,233,580.73
非流动负债合计9,483,967.2910,179,860.3710,458,453.2811,076,218.66
负债合计138,843,500.37133,819,200.5124,941,331.4119,309,799.39
归属于母公司股东权益合计648,958,635.51635,529,063.73676,924,676.83668,550,165.32
股东权益合计648,958,635.51635,529,063.73676,924,676.83668,550,165.32
负债和股东权益合计787,802,135.88769,348,264.23801,866,008.23787,859,964.71
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计191,603,830.7126,232,865.9267,850,571.06301,506,983.21
经营活动现金流出小计136,288,060.2291,048,288.1451,340,444.49270,445,109.18
经营活动产生的现金流量净额55,315,770.4835,184,577.7816,510,126.5731,061,874.03
投资活动现金流入小计218,736,213.26113,237,581.4246,599,181.42134,513,963.21
投资活动现金流出小计377,314,452.34249,555,46231,004,727213,738,460.14
投资活动产生的现金流量净额-158,578,239.08-136,317,880.5815,594,454.42-79,224,496.93
筹资活动现金流入小计27,380,732.222,646,798.0112,785,666.0568,298,135.2
筹资活动现金流出小计49,481,106.4849,153,447.56274,771.73152,764,358.95
筹资活动产生的现金流量净额-22,100,374.28-26,506,649.5512,510,894.32-84,466,223.75
汇率变动对现金及现金等价物的影响-249,972.0969,308.6414,490.42-96,065.23
现金及现金等价物净增加额-125,612,814.97-127,570,643.7144,629,965.73-132,724,911.88
期末现金及现金等价物余额35,529,374.6933,571,545.95205,772,155.39161,142,189.66
TOP↑